Search 

AriVan Research LLC (AVR) is a specialized consulting firm that works closely with biopharmaceutical companies, diagnostic companies, medical device manufacturers, and other clients to support business development, commercialization and R&D activities.  Our expertise involves conducting in-depth primary research with KOLs, clinical investigators, healthcare company personnel, payers, and other industry sources to address important business- and scientific-related questions and issues.  A thorough analysis of secondary and/or audit data is often completed as well.  From there, our highly-experienced group of MBAs, MDs & PharmDs analyzes the information to provide rational and insightful recommendations.  

BioPharm Insight is the premier online business intelligence tool used by most Business Development and Strategy teams- to help them more efficiently target, track and identify opportunitues and the competitive landscape. The best way to understand how you can leverage you personalized radar of real-time and proprietary intel, detailed deal comps, and forecasts, is to see an online demo of the tool. Please suggest the best time and place for us to show you exactly how we can help or visit us at www.biopharminsight.com

Campbell Alliance is the Consulting business segment of inVentiv Health, a leading global provider of best-in-class clinical, commercial, and consulting services to companies seeking to accelerate performance. The firm’s clients include all of the world’s top-20 pharmaceuti­cal companies, hundreds of emerging and midsize biopharmaceutical companies, as well as a number of medical device and diagnostics companies. Campbell Alliance is organized into practice areas, each specializing in a critical industry function: Brand Management, Clinical Development, Commercial Effectiveness, Corporate Development, Medical Affairs, and Pricing and Market Access. From its locations in Cambridge, MA; Conshohocken, PA; Deerfield, IL; London, UK; Newtown, PA; New York, NY; Parsippany, NJ; Raleigh, NC; Somerset, NJ; South San Francisco, CA; Thousand Oaks, CA; and Zug, Switzerland, the firm serves clients throughout North America, Europe, and Japan.

EvaluatePharma®, leader in life science sector analysis, delivers exclusive commercial intelligence and analysis into industry performance globally.

With 10+ years’ experience and investment in our services, we provide meaningful, value-added information and analysis that aids in target identification, strategic decision-making, and risk mitigation aimed towards your competitive advantage and business results.

Our flexible, “one-stop” services include:
EvaluatePharma® featuring all the Deals Data you need for Business Development, Proprietary Data Standardization, Merge Company tool, Calendar of Events, Interactive NPV Analyzer, Sales by Indication and Consensus Forecasts for Marketed & Pipeline Products, plus much more to give you the most accurate view of the global market.

EP Clinical Trials simplifies complex analysis of the global clinical trials landscape including ClinicalTrials.gov, EudraCT and Japan clinical trials data source for trusted clinical intelligence you can rely on, and the time savings you need.

EvaluatePharma® Partnering Services make finding your next licensing partner easier, and features the latest assets available for partnering presented in their commercial context alongside our unique industry analysis.

EPVantage® renowned news service provides mapped commentary and analysis that keeps you abreast of the latest sector developments relevant to you.

Discover why EvaluatePharma is trusted and relied upon by life science companies big and small, the investment community and leading consultancies.

You can count on EvaluatePharma for:

• Product Forecasts to 2018
• New – Sales by Indication to 2018
• Product Deals
• M&A Transactions
• Product Historic Sales
• Clinical Trials
• Country Analysis
• Archived Historical Sales Forecasts
• Company profiles
• Drug Information
• R&D Pipelines
• Patent Risk
• News
• NPV’s of Marketed and Pipeline Products
• Calendar of Events - key events that will shape the future of the industry
• EP Vantage & Event Analyzer - analysis and commentary on key market events

Foley Hoag is a preeminent Life Sciences law firm that represents public and private clients in a wide range of transactions worldwide.  The chair of our Licensing and Strategic Alliances practice group together with one of our leading Intellectual Property partners will be available to meet with interested companies.

Fujifilm Diosynth is a leading provider of process development and cGMP manufacturing services for biopharmaceuticals. Fujifilm Diosynth offers a proven track record in process development and cGMP manufacturing of cell culture and microbial expressed proteins, vaccines, and monoclonal antibodies. The organization has facilities in Research Triangle Park, North Carolina, USA (formerly Diosynth Biotechnology) and Billingham, UK (formerly Avecia Biologics) and was acquired by Fujifilm Corporation in April 2011.  Combined, Fujifilm Diosynth brings to our clients over 25 years of experiences as a contract manufacturing organization. 

GLG Research partners with organizations seeking efficient, targeted connections to insight.

Our Healthcare Practice provides you with access to expert insights on issues affecting the pharmaceutical, biotechnology, medical device, and healthcare services sectors. GLG works with:

• 9 of the top 10 pharmaceutical and biotechnology companies
• More than 80,000 experts from across the entire healthcare industry including physicians, researchers, scientists, payors, and healthcare industry executives
• 7 out of the top 10 global medical equipment companies
• Over 300,000 experts from all sectors, including former C-level operating executives, ex-top-tier strategy consultants and thought leaders from around the world